Abstract
The present research focuses on the molecular docking analysis of the isolated compound from the seaweed “Sargassum wightii” on cancer specific HER2 or HER2/neu also known as CD340. The ethanol derived compounds capable of binding to HER2 receptor is implicated for the breast cancer. The crystal structure of the HER2 protein with the resolution of 1.63Ao (Pdb entry 4RJ3) collected from the pdb website (www.pdb). Missing alignments and the side chains are prepared to fit for the insilico analysis. Seven bioactive compounds isolated from the hydro-alcoholic mixture using GC-MS are docked against HER2 using Schrodinger 2013.1 (Glide version 5.9). The binding sites, glide score and the energy of the 7 compounds with the HER2 protein are compared. The isolated compounds with most negative glide score such as benzoic acid, 2-hydroxy-ethyl ester, methyl salicylate, diethyl phthalate and phytol exhibited efficient in inhibiting the HER2 receptor of breast cancer. The Pharmacokinetics and Pharmacodynamics (ADME) properties of the selected highest glide scored compounds are performed using QikProp 3.6 module from Schrodinger-Maestro software. The compounds were showed significant ADME properties in basic criteria of Molecular weight (MW), H-Bond donor, H-Bond acceptor and log P (O/W). The results of the study showed that the compounds of “Sargassum wightii” may be a good target for breast Cancer.
Keywords: HER2/neu, Sargassum wightii, breast cancer, Schrodinger maestro, in-Silico analysis and QikProp.
The Natural Products Journal
Title:Screening of Potential Anticancer Compounds from Sargassum wightii to Target Breast Cancer Specific HER2 Receptor using in-silico Analysis
Volume: 6 Issue: 2
Author(s): P. Balachandran, T. V. Ajay Kumar and V. Parthasarathy
Affiliation:
Keywords: HER2/neu, Sargassum wightii, breast cancer, Schrodinger maestro, in-Silico analysis and QikProp.
Abstract: The present research focuses on the molecular docking analysis of the isolated compound from the seaweed “Sargassum wightii” on cancer specific HER2 or HER2/neu also known as CD340. The ethanol derived compounds capable of binding to HER2 receptor is implicated for the breast cancer. The crystal structure of the HER2 protein with the resolution of 1.63Ao (Pdb entry 4RJ3) collected from the pdb website (www.pdb). Missing alignments and the side chains are prepared to fit for the insilico analysis. Seven bioactive compounds isolated from the hydro-alcoholic mixture using GC-MS are docked against HER2 using Schrodinger 2013.1 (Glide version 5.9). The binding sites, glide score and the energy of the 7 compounds with the HER2 protein are compared. The isolated compounds with most negative glide score such as benzoic acid, 2-hydroxy-ethyl ester, methyl salicylate, diethyl phthalate and phytol exhibited efficient in inhibiting the HER2 receptor of breast cancer. The Pharmacokinetics and Pharmacodynamics (ADME) properties of the selected highest glide scored compounds are performed using QikProp 3.6 module from Schrodinger-Maestro software. The compounds were showed significant ADME properties in basic criteria of Molecular weight (MW), H-Bond donor, H-Bond acceptor and log P (O/W). The results of the study showed that the compounds of “Sargassum wightii” may be a good target for breast Cancer.
Export Options
About this article
Cite this article as:
Balachandran P., V. Ajay Kumar T. and Parthasarathy V., Screening of Potential Anticancer Compounds from Sargassum wightii to Target Breast Cancer Specific HER2 Receptor using in-silico Analysis, The Natural Products Journal 2016; 6 (2) . https://dx.doi.org/10.2174/2210315506666160218224112
DOI https://dx.doi.org/10.2174/2210315506666160218224112 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Bariatric Surgery - Effects on Obesity and Related co-Morbidities
Current Diabetes Reviews Vitamin D3 and Vitamin D3 Analogues as an Adjunct to Cancer Chemotherapy and Radiotherapy
Current Medicinal Chemistry - Anti-Cancer Agents The Endothelin Axis as Therapeutic Target in Human Malignancies: Present and Future
Current Pharmaceutical Design Imaging Drug Resistance with Radiolabeled Molecules
Current Pharmaceutical Design The Diagnostic Utility of Pleural Fluid Tests in Clinical Practice
Current Respiratory Medicine Reviews The Anti-Tumor Activity of Afatinib in Pancreatic Ductal Adenocarcinoma Cells
Anti-Cancer Agents in Medicinal Chemistry Cytokine Status of Serum in Ovarian Cancer Patients with Different Tumor Neoadjuvant Chemotherapy Response
Anti-Cancer Agents in Medicinal Chemistry Salivary Total Sialic Acid Levels Increase in Breast Cancer Patients: A Preliminary Study
Medicinal Chemistry Endothelial Progenitor Cells: Hope Beyond Controversy
Current Cancer Drug Targets Surface Plasmon Resonance Imaging Sensor for Cathepsin Determination Based on Immobilized Cystatin
Protein & Peptide Letters PET Radiopharmaceuticals for Personalized Medicine
Current Drug Targets Neopterin as a Marker for Immune System Activation
Current Drug Metabolism Blockade of Neoangiogenesis, a New and Promising Technique to Control the Growth of Malignant Tumors and their Metastases
Current Vascular Pharmacology Role of MMPs in Metastatic Dissemination: Implications for Therapeutic Advances
Current Pharmaceutical Biotechnology Selective Targeted Drug Delivery Mechanism via Molecular Imprinted Polymers in Cancer Therapeutics
Current Topics in Medicinal Chemistry Parametric MR Dynamic Imaging for Breast Lesions Characterization and Prediction of Lymph Nodes Involvement
Current Radiopharmaceuticals Targeted Nanosystems for Cancer Therapy
Current Cancer Therapy Reviews Mechanism-Based Treatment in Chronic Neuropathic Pain: The Role of Antidepressants
Current Pharmaceutical Design The Combination of FDG PET/CT and Contrast Enhanced CT in the Evaluation of Recurrent Pancreatic Carcinoma and Cholangiocarcinoma
Current Medical Imaging Interactions of the Aryl Hydrocarbon Receptor with Inflammatory Mediators:Beyond CYP1A Regulation
Current Drug Metabolism